AUSTIN – Natera Inc has acquired Foresight Diagnostics, a move that expands its portfolio of tests that detect trace amounts of cancer left after treatment, in a deal worth up to $450 million. The all-stock transaction includes a $275 million…
CAMBRIDGE: EDX Medical Group plc has secured up to £4 million in funding to advance its portfolio of digital diagnostic products and services, the company announced Monday. The financing includes £2 million raised through the issue of 14,285,713 new ordinary…
CHICAGO: Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence-driven precision medicine, announced Friday it has acquired Paige, a digital pathology company known for pioneering FDA-cleared AI applications in cancer detection. The $81.25 million deal, primarily paid in Tempus…